The combination of amlodipine 5 mg and valsartan 160 mg lowers blood pressure effectively and safely in hypertensive patients not controlled by monotherapy with calcium channel blockers

被引:0
|
作者
Brachmann, J. [1 ]
Handrock, R. [2 ]
Klebs, S. [2 ]
机构
[1] Coburg Hosp, Dept Cardiol, Coburg, Germany
[2] Novartis Pharma GmbH, Clin & Regulatory Affairs, Nurnberg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E450 / E450
页数:1
相关论文
共 50 条
  • [21] Valsartan 160/HCTZ 25 effectively reduces blood pressure in hypertensive patients not controlled by valsartan 160/HCTZ 12.5
    Trenkwalder, P
    Ulmer, HJ
    Wolf, H
    Handrock, R
    JOURNAL OF HYPERTENSION, 2004, 22 : S391 - S391
  • [22] Valsartan 160/HCTZ 25 effectively reduces blood pressure in hypertensive patients not controlled by valsartan 160/HCTZ 12.5
    Trenkwalder, P
    Ulmer, HJ
    Wolf, H
    Handrock, R
    JOURNAL OF HYPERTENSION, 2004, 22 : S194 - S194
  • [23] Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy
    Sinkiewicz, W.
    Glazer, R. D.
    Kavoliuniene, A.
    Miglinas, M.
    Prak, H.
    Wernsing, M.
    Yen, J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (02) : 315 - 324
  • [24] Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy
    Schunkert, H.
    Glazer, R. D.
    Wernsing, M.
    Yen, J.
    Macarie, C. E.
    Vintila, M. M.
    Romanova, J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (11) : 2655 - 2662
  • [25] Efficacy and tolerability of HCTZ 25 mg in combination with valsartan 160 mg in hypertensive patients not adequately controlled with a combination of high doses of ARBs and HCTZ 12,5 mg
    Girerd, X
    Denolle, T
    Brunel, P
    Yau, C
    Fiquet, B
    Moulin, B
    Herpin, D
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 107A - 108A
  • [26] EFFICACY OF AN AMLODIPINE/VALSARTAN COMBINATION ON BLOOD PRESSURE CONTROL, WITH ONE EVENING OR MORNING INTAKE A DAY, IN ESSENTIAL HYPERTENSIVE PATIENTS UNCONTROLLED WITH AMLODIPINE 5 MG: EXPERT STUDY
    Asmar, R.
    Gosse, R.
    Achouba, A.
    JOURNAL OF HYPERTENSION, 2009, 27 : S8 - S8
  • [27] Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy
    Tuomilehto, Jaakko
    Tykarski, Andrzej
    Baumgart, Peter
    Reimund, Bernard
    Le Breton, Stephanie
    Ferber, Philippe
    BLOOD PRESSURE, 2008, 17 : 15 - 23
  • [28] Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination
    Schweizer, J.
    Hilsmann, U.
    Neumann, G.
    Handrock, R.
    Klebs, S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2877 - 2885
  • [29] VALSARTAN/AMLODIPINE COMBINATION IN ELDERLY HYPERTENSIVE PATIENTS: AMBULATORY BLOOD PRESSURE AND CHRONOTHERAPY
    Lopez Paz, J. E.
    Hermida Ameijeiras, A.
    Pena Seijo, M.
    Calvo Gonzalez, G.
    Romero Miguez, M. L.
    Coca Payeras, A.
    Calvo Gomez, C.
    JOURNAL OF HYPERTENSION, 2010, 28 : E100 - E100
  • [30] Efficacy and Safety of Valsartan 160mg/Hydrochlorothiazide 25mg Combination in Patients with Hypertension not Adequately Controlled by Valsartan 160mg/ Hydrochlorothiazide 12.5mg
    Peter Trenkwalder
    Hans-Joachim Ulmer
    Gottfried Weidinger
    Renate Handrock
    Clinical Drug Investigation, 2004, 24 : 593 - 602